Cisplatin-epirubicin-paclitaxel weekly administration with G-CSF support in advanced breast cancer. A Southern Italy Cooperative Oncology Group (SICOG) phase II study.
about
Weekly dose-dense cisplatin-epirubicin-paclitaxel administration with granulocyte colony-stimulating factor support does not substantially improve prognosis in extensive disease small-cell lung cancer. A SICOG phase II study.Weekly cisplatin, epirubicin, and paclitaxel with granulocyte colony-stimulating factor support vs triweekly epirubicin and paclitaxel in locally advanced breast cancer: final analysis of a sicog phase III study.Modified weekly regimen of cisplatin, epirubicin and paclitaxel induced a durable response in two cases of metastatic extramammary Paget's disease.Preoperative weekly cisplatin, epirubicin, and paclitaxel (PET) improves prognosis in locally advanced breast cancer patients: an update of the Southern Italy Cooperative Oncology Group (SICOG) randomised trial 9908.Preoperative weekly cisplatin-epirubicin-paclitaxel with G-CSF support in triple-negative large operable breast cancer.Weekly cisplatin plus capecitabine in metastatic breast cancer patients heavily pretreated with both anthracycline and taxanes.
P2860
Cisplatin-epirubicin-paclitaxel weekly administration with G-CSF support in advanced breast cancer. A Southern Italy Cooperative Oncology Group (SICOG) phase II study.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Cisplatin-epirubicin-paclitaxe ...... Group (SICOG) phase II study.
@ast
Cisplatin-epirubicin-paclitaxe ...... Group (SICOG) phase II study.
@en
Cisplatin-epirubicin-paclitaxe ...... aly Cooperative Oncology Group
@nl
type
label
Cisplatin-epirubicin-paclitaxe ...... Group (SICOG) phase II study.
@ast
Cisplatin-epirubicin-paclitaxe ...... Group (SICOG) phase II study.
@en
Cisplatin-epirubicin-paclitaxe ...... aly Cooperative Oncology Group
@nl
prefLabel
Cisplatin-epirubicin-paclitaxe ...... Group (SICOG) phase II study.
@ast
Cisplatin-epirubicin-paclitaxe ...... Group (SICOG) phase II study.
@en
Cisplatin-epirubicin-paclitaxe ...... aly Cooperative Oncology Group
@nl
P2093
P2860
P356
P1476
Cisplatin-epirubicin-paclitaxe ...... Group (SICOG) phase II study.
@en
P2093
D'Aniello R
De Lucia L
Di Bonito M
P2860
P2888
P356
10.1023/A:1006429205363
P407
P577
2000-07-01T00:00:00Z
P6179
1049130520